Compare USFD & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | USFD | ILMN |
|---|---|---|
| Founded | 2007 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Distributors | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.9B | 19.4B |
| IPO Year | 2016 | 2000 |
| Metric | USFD | ILMN |
|---|---|---|
| Price | $91.18 | $139.88 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 17 |
| Target Price | $103.64 | ★ $124.24 |
| AVG Volume (30 Days) | ★ 1.7M | 1.4M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 45.54 | ★ 170.87 |
| EPS | ★ 2.94 | 0.87 |
| Revenue | ★ $39,424,000,000.00 | $4,343,000,000.00 |
| Revenue This Year | $7.63 | $6.47 |
| Revenue Next Year | $3.92 | $5.58 |
| P/E Ratio | $31.68 | ★ $24.72 |
| Revenue Growth | ★ 4.08 | N/A |
| 52 Week Low | $66.62 | $73.86 |
| 52 Week High | $102.13 | $155.53 |
| Indicator | USFD | ILMN |
|---|---|---|
| Relative Strength Index (RSI) | 48.31 | 63.00 |
| Support Level | $87.89 | $137.00 |
| Resistance Level | $94.29 | $153.43 |
| Average True Range (ATR) | 2.24 | 5.18 |
| MACD | 0.01 | 0.61 |
| Stochastic Oscillator | 38.40 | 94.98 |
US Foods Holding Corp is a U.S. food service distributor that distributes food and nonfood products to the healthcare and hospitality industries, restaurants, education, government facilities, and grocers. It has various customer locations across the United States, with a vast network of distribution facilities, a fleet of trucks, and cash and carry locations offering food and non-food products, and a comprehensive suite of e-commerce, technology, and business solutions to its customers. The company operates in one business segment in which it markets, sells, and distributes fresh, frozen, and dry food and non-food products to foodservice customers throughout the U.S. The products offered are as snacks, beverages, fresh produce, sauces, condiments, canned/frozen fruits and others.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.